administering tirzepatide HOW TO INJECT YOUR SEMAGLUTIDE OR // Dr. G Demonstrates Step-by-Step with a Patient Tirzepatide for Medical Weight Loss
Description
The RECOLAR trial was a phase 4, double-blind, randomized, 4-armed crossover study conducted from September 2020 to September 2021

A secondary analysis of a study, shared at the 32nd European Congress on Obesity in Spain in May, found semaglutide may help decrease the risk of death from any cause, death from cardiovascular causes, combined heart failure outcomes and major adverse cardiovascular events after just six months

A subgroup analysis revealed that GLP-1 users with RA had fewer heart attacks, strokes, and deaths from cardiovascular causes than those on a different diabetes medication

Dermatologists can perform more detailed assessments, including trichoscopy or scalp biopsy where indicated, to exclude other diagnoses such as androgenetic alopecia, alopecia areata, or scarring alopecia, which require different management approaches

Set a schedule: Don't wait until you feel thirsty
Both tirzepatide and certain GLP-1 receptor agonists show some degree of this pattern for gastric emptying after repeated doses
